The HPB-AML-I cell line possesses the properties of mesenchymal stem cells

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Ardianto, Bambang ^a   Sugimoto, Takeshi ^a   Kawano, Seiji ^a   Kasagi, Shimpei ^a   Jauharoh, Siti Na ^a   Kurimoto, Chiyo ^a   Tatsumi, Eiji ^b   Morikawa, Keiko ^b   Kumagai, Shunichi ^a   Hayashi, Yoshitake ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAGAMI WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ALKALINE PHOSPHATASE; BETA1 INTEGRIN; CD14 ANTIGEN; CD19 ANTIGEN; CD34 ANTIGEN; CD44V ANTIGEN; CD45 ANTIGEN; CD59 ANTIGEN; DECAY ACCELERATING FACTOR; ENDOGLIN; FAT DROPLET; HLA DR ANTIGEN; HYDROCORTISONE; INDOMETACIN; ISOBUTYLMETHYLXANTHINE; MEMBRANE ANTIGEN; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; TRANSCRIPTION FACTOR RUNX1;

ACUTE GRANULOCYTIC LEUKEMIA; ADIPOCYTE; ANTIGEN EXPRESSION; ARTICLE; CARTILAGE CELL; CD3+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SURFACE; CYTOCHEMISTRY; CYTOGENETICS; EXTRACELLULAR MATRIX; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; KARYOTYPE; LIPID STORAGE; LYMPHOCYTE CULTURE; MESENCHYMAL STEM CELL; OSTEOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEOGLYCAN SYNTHESIS; CANCER STEM CELL; CYTOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL LINEAGE; HUMANS; MESENCHYMAL STEM CELLS; NEOPLASTIC STEM CELLS;

EID: 78649956869     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-163     Document Type: Article

References (36)

1. Regulation of stemness and stem cell niche of mesenchymal stem cells: implications in tumorigenesis and metastasis. NZ Kuhn RS Tuan, J Cell Physiol 2010 222 268 277 10.1002/jcp.21940 19847802
2. Bone marrow mesenchymal stem cells. M Ohishi E Schipani, J Cell Biochem 2010 109 277 282 19950205
3. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. K Le Blanc L Tammik B Sundberg SE Haynesworth O Ringden, Scand J Immunol 2003 57 11 20 10.1046/j.1365-3083.2003.01176.x 12542793
4. Therapeutic potential of adult bone marrow-derived mesenchymal stem cells in diseases of the skeleton. D Chanda S Kumar S Ponnazhagan, J Cell Biochem 2010 111 2 249 57 10.1002/jcb.22701 20506559
5. The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. MJ Hoogduijn F Popp R Verbeek M Masoodi A Nicolaou C Baan MH Dahlke, Int Immunopharmacol 2010 10 12 1496 500 Epub 2010 Jul 7 10.1016/j.intimp.2010.06.019 20619384
6. Concise review: hitting the right spot with mesenchymal stromal cells. J Tolar K Le Blanc A Keating BR Blazar, Stem Cells 2010 28 1446 1455 10.1002/stem.459 20597105
7. CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. AS Adhikari N Agarwal BM Wood C Porretta B Ruiz RR Pochampally T Iwakuma, Cancer Res 2010 70 4602 4612 10.1158/0008-5472. CAN-09-3463 20460510
8. Identification of cancer stem cells in Ewing's sarcoma. ML Suva N Riggi JC Stehle K Baumer S Tercier JM Joseph D Suva V Clement P Provero L Cironi MC Osterheld L Guillou I Stamenkovic, Cancer Res 2009 69 1776 1781 10.1158/0008-5472.CAN-08-2242 19208848
9. A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma. S Boeuf P Kunz T Hennig B Lehner P Hogendoorn J Bovee W Richter, J Pathol 2008 216 158 166 10.1002/path.2389 18702172
10. Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia. S Shalapour C Eckert K Seeger M Pfau J Prada G Henze T Blankenstein T Kammertoens, J Mol Med 2010 88 249 265 10.1007/s00109-009-0583-8 20155409
11. Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene. P Menendez P Catalina R Rodriguez GJ Melen C Bueno M Arriero F Garcia-Sanchez A Lassaletta R Garcia-Sanz J Garcia-Castro, J Exp Med 2009 206 3131 3141 10.1084/jem.20091050 19995953
12. Establishment of a human preadipose cell line, HPB-AML-I: refractory to PPARgamma-mediated adipogenic stimulation. I Torii S Morikawa A Nakano K Morikawa, J Cell Physiol 2003 197 42 52 10.1002/jcp.10326 12942539
13. Combination of hTERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential. T Mori T Kiyono H Imabayashi Y Takeda K Tsuchiya S Miyoshi H Makino K Matsumoto H Saito S Ogawa M Sakamoto J Hata A Umezawa, Mol Cell Biol 2005 25 5183 5195 10.1128/MCB.25.12.5183-5195.2005 15923633
14. Can the life span of human marrow stromal cells be prolonged by bmi-1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation? Y Takeda T Mori H Imabayashi T Kiyono S Gojo S Miyoshi N Hida M Ita K Segawa S Ogawa M Sakamoto S Nakamura A Umezawa, J Gene Med 2004 6 833 845 10.1002/jgm.583 15293342
15. Immortalization of human fetal cells: the life span of umbilical cord blood-derived cells can be prolonged without manipulating p16INK4a/RB braking pathway. M Terai T Uyama T Sugiki XK Li A Umezawa T Kiyono, Mol Biol Cell 2005 16 1491 1499 10.1091/mbc.E04-07-0652 15647378
16. A rapid banding technique for human chromosomes. M Seabright, Lancet 1971 2 971 972 10.1016/S0140-6736(71)90287-X 4107917
17. Multicolor spectral karyotyping of human chromosomes. E Schrock S du Manoir T Veldman B Schoell J Wienberg MA Ferguson-Smith Y Ning DH Ledbetter I Bar-Am D Soenksen Y Garini T Ried, Science 1996 273 494 497 10.1126/science.273. 5274.494 8662537
18. Identification of mesenchymal stem cells in aorta-gonad-mesonephros and yolk sac of human embryos. XY Wang Y Lan WY He L Zhang HY Yao CM Hou Y Tong YL Liu G Yang XD Liu X Yang B Liu N Mao, Blood 2008 111 2436 2443 10.1182/blood-2007-07-099333 18045971
19. Stage-related capacity for limb chondrogenesis in cell culture. PB Ahrens M Solursh RS Reiter, Dev Biol 1977 60 69 82 10.1016/0012-1606(77)90110-5 198274
20. The patterns on chondrogenesis of cells from facial primordia of chick embryos in micromass culture. SE Wedden MR Lewin-Smith C Tickle, Dev Biol 1986 117 71 82 10.1016/0012-1606(86)90349-0 3743900
21. A novel tumor cell line cloned from mutated human embryonic bone marrow mesenchymal stem cells. W Xu H Qian W Zhu Y Chen Q Shao X Sun J Hu C Han X Zhang, Oncol Rep 2004 12 501 508 15289828
22. Changes in surface markers of human mesenchymal stem cells during the chondrogenic differentiation and dedifferentiation processes in vitro. HJ Lee BH Choi BH Min SR Park, Arthritis Rheum 2009 60 2325 2332 10.1002/art.24786 19644865
23. Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. I Majore P Moretti R Hass C Kasper, Cell Commun Signal 2009 7 6 10.1186/1478-811X-7-S1-A6 19302702
24. Isolation of cancer stem cells from transformed human mesenchymal stem cell line F6. X Xu H Qian W Zhu X Zhang Y Yan M Wang W Xu, J Mol Med 2010 88 11 1181 90 Epub 10.1007/s00109-010-0659-5 20697686
25. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis. MR Choi HY Kim JY Park TY Lee CS Baik YG Chai KH Jung KS Park W Roh KS Kim SH Kim, Neurosci Lett 2010 472 94 98 10.1016/j.neulet.2010.01.054 20117176
26. Characterization of two populations of mesenchymal progenitor cells in umbilical cord blood. YJ Chang CP Tseng LF Hsu TB Hsieh SM Hwang, Cell Biol Int 2006 30 495 499 10.1016/j.cellbi.2005.12.009 16731010
27. Potent in vitro chondrogenesis of CD105 enriched human adipose-derived stem cells. T Jiang W Liu X Lv H Sun L Zhang Y Liu WJ Zhang Y Cao G Zhou, Biomaterials 2010 31 3564 3571 10.1016/j.biomaterials.2010.01.050 20153525
28. Differentiation of adipose-derived stromal vascular fraction culture cells into chondrocytes using the method of cell sorting with a mesenchymal stem cell marker. D Ishimura N Yamamoto K Tajima A Ohno Y Yamamoto O Washimi H Yamada, Tohoku J Exp Med 2008 216 149 156 10.1620/tjem.216.149 18832797
29. Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q-syndrome. O Lopez-Villar JL Garcia FM Sanchez-Guijo C Robledo EM Villaron P Hernandez-Campo N Lopez-Holgado M Diez-Campelo MV Barbado JA Perez-Simon JM Hernandez-Rivas JF San-Miguel MC del Canizo, Leukemia 2009 23 664 672 10.1038/leu.2008.361 19151777
30. Mesenchymal stem cells can be easily isolated from bone marrow of patients with various haematological malignancies but the surface antigens expression may be changed after prolonged ex vivo culture. SP Yeh JG Chang CL Lin WJ Lo CC Lee CY Lin CF Chiu, Leukemia 2005 19 1505 1507 10.1038/sj.leu. 2403795 15902289
31. Induction of CD45 expression on bone marrow-derived mesenchymal stem cells. SP Yeh JG Chang WJ Lo YC Liaw CL Lin CC Lee CF Chiu, Leukemia 2006 20 894 896 10.1038/sj.leu.2404181 16525488
32. In vitro and in vivo immunosuppressive characteristics of hepatocyte growth factor-modified murine mesenchymal stem cells. L Bian ZK Guo HX Wang JS Wang H Wang QF Li YF Yang FJ Xiao CT Wu LS Wang, In Vivo 2009 23 21 27 19368120
33. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patient with hematological malignant diseases. Z Zhi-Gang L Wei-Ming C Zhi-Chao Y Yong Z Ping, Leuk Lymphoma 2008 49 2187 2195 10.1080/ 10428190802455875 19021063
34. Immunosuppressive properties of mesenchymal stem cells derived from bone marrow of patients with chronic myeloid leukemia. ZG Zhao WM Li ZC Chen Y You P Zou, Immunol Invest 2008 37 726 739 10.1080/08820130802349940 18821219
35. Bone marrow derived mesenchymal stem cells from chronic myeloid leukemia t(9;22) patients are devoid of Philadelphia chromosome and support cord blood stem cell expansion. S Jootar N Pornprasertsud S Petvises B Rerkamnuaychoke S Disthabanchong S Pakakasama A Ungkanont S Hongeng, Leuk Res 2006 30 1493 1498 10.1016/j.leukres.2006.04.013 16839603
36. Assessment of bone marrow mesenchymal stem cell biological characteristics and support hemotopoiesis function in patients with chronic myeloid leukemia. Z Zhao X Tang Y You W Li F Liu P Zou, Leuk Res 2006 30 993 1003 10.1016/j.leukres.2005.12.010 16448696